Skip to content
Screener

Innoviva, Inc. INVA Q1 2025 earnings

Reported May 7, 2025 · Before market open

Revenue$88.6MBeat by $6.0M
EPS$0.25Miss by $0.04
Revenue estimate$82.7M
EPS estimate$0.29

Next report

Nov 4, 2026 (in a month)
Revenue estimate$115.3M
EPS estimate$0.49

Financials

Q1 2025

Income statement

See full
Revenue$88.6M+14.4%
Gross profit$73.3M+22.0%
Operating income$41.4M+60.5%
Net income-$46.6M-228%
EPS (diluted)-$0.74-261%

Balance sheet

See full
Cash & equivalents$319.1M+78.9%
Total debt$451.3M+0.4%
Total assets$1.3B-1.0%

Cash flow

See full
Operating cash flow$48.6M+31.2%
CapEx-—
Free cash flow$48.6M+31.2%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.14B+17.9%
Enterprise value$1.27B+2.7%
P/S3.1×0.0×

Profitability

See full
Gross margin83.7%+5.2pp
Operating margin49.3%+13.6pp
Net margin-16.1%-74.4pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Current ratio2.5×-7.9×

Segments

By product

See full
Giapreza$18.3M+51.3%
Cost Reimbursement$600.0K—

FAQ

When did Innoviva, Inc. report Q1 2025 earnings?
Innoviva, Inc. (INVA) reported Q1 2025 earnings on May 7, 2025 before market open.
What were Innoviva, Inc.'s Q1 2025 revenue and EPS?
Innoviva, Inc. reported revenue of $88.6M and eps of $0.25 for Q1 2025.
Did Innoviva, Inc. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $82.7M by $6.0M. EPS missed the consensus estimate of $0.29 by $0.04.
How did Innoviva, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.5% from $81.0M a year earlier and eps declined 45.7% from $0.46.
Where can I find Innoviva, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-045556) and the 10-Q periodic report (0000950170-25-065765) directly on SEC EDGAR. The filing index links above go to sec.gov.